Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors
Study Number: URCC 18007
Study Summary:
This phase III trial studies how well bupropion works in reducing cancer related fatigue in stage I-III breast cancer survivors. Bupropion is a drug that is used to treat depression, as well as to help people quit smoking. Cancer and its treatment can cause fatigue. Giving bupropion may improve cancer related fatigue in breast cancer survivors.
Status: Open
Study Coordinator(s)
- Courtney, 309-243-3660 cbrown@illinoiscancercare.com
- Hannah S, 309-243-3603, hshearburn@illinoiscancercare.com
- Kelsey, 309-243-3618 kfay@illinoiscancercare.com
